MOL-4249

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameMOL-4249
Drug Alias NameMOL-4249
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSignal transducer and activator of transcription 5A inhibitorsSignal transducer and activator of transcription 3 inhibitorsSignal transducer and activator of transcription 5B inhibitors
TargetsSignal transducer and activator of transcription 5BSignal transducer and activator of transcription 3Signal transducer and activator of transcription 5A
Therapy Area/IndicationsPsoriasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMoleculin Llc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMoleculin Llc
Active IndicationsN/A
Inactive IndicationsPsoriasis

Other Information

ATC CodeN/A
Related LinksN/A